Date | Company Name | Round | Money Raised | Industry | Lead Investor |
---|---|---|---|---|---|
Jan 6, 2022 | Eikon Therapeutics | Series B | — | Biotechnology | — |
Oct 21, 2021 | ReCode Therapeutics | Series B | — | Biopharma | Yes |
Jan 7, 2021 | Scorpion Therapeutics | Series B | — | Biotechnology | Yes |
Sep 14, 2020 | Neogene Therapeutics | Series A | — | Biotechnology | Yes |
Aug 26, 2020 | Freenome | Series C | — | Biotechnology | — |
Aug 9, 2019 | ORIC Pharmaceuticals | Series D | — | Biotechnology | — |
Oct 17, 2018 | Avidity Biosciences | Series B | — | Biotechnology | — |
Feb 21, 2018 | ORIC Pharmaceuticals | Series C | — | Biotechnology | — |
Nov 13, 2017 | Arcus Biosciences | Series C | — | Biotechnology | — |
Jul 18, 2016 | Ardelyx | Post-IPO Equity | — | Biotechnology | — |
Dec 2, 2015 | ORIC Pharmaceuticals | Series B | — | Biotechnology | — |
Sep 1, 2015 | Intellia Therapeutics | Series B | — | Biotechnology | — |
Sep 8, 2014 | Flex Pharma | Series Unknown | — | Biotechnology | — |